A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)

NCT00734097 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

314

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Esomeprazole 40 mg
PROCEDURE: Physical Exam
OTHER: Quality of Life Questionnaires
PROCEDURE: pregnancy test, if applicable

Sponsor

AstraZeneca